[go: up one dir, main page]

FR2539412B1 - 5-FLUORURACIL DERIVATIVES AND THEIR THERAPEUTIC USES AS CARCINOSTATIC AGENTS - Google Patents

5-FLUORURACIL DERIVATIVES AND THEIR THERAPEUTIC USES AS CARCINOSTATIC AGENTS

Info

Publication number
FR2539412B1
FR2539412B1 FR8300457A FR8300457A FR2539412B1 FR 2539412 B1 FR2539412 B1 FR 2539412B1 FR 8300457 A FR8300457 A FR 8300457A FR 8300457 A FR8300457 A FR 8300457A FR 2539412 B1 FR2539412 B1 FR 2539412B1
Authority
FR
France
Prior art keywords
fluoruracil
derivatives
therapeutic uses
carcinostatic agents
carcinostatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8300457A
Other languages
French (fr)
Other versions
FR2539412A1 (en
Inventor
Shoichiro Ozaki
Tomonori Hoshiko
Tomio Ogasawara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR8300457A priority Critical patent/FR2539412B1/en
Publication of FR2539412A1 publication Critical patent/FR2539412A1/en
Application granted granted Critical
Publication of FR2539412B1 publication Critical patent/FR2539412B1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8300457A 1983-01-13 1983-01-13 5-FLUORURACIL DERIVATIVES AND THEIR THERAPEUTIC USES AS CARCINOSTATIC AGENTS Expired FR2539412B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR8300457A FR2539412B1 (en) 1983-01-13 1983-01-13 5-FLUORURACIL DERIVATIVES AND THEIR THERAPEUTIC USES AS CARCINOSTATIC AGENTS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8300457A FR2539412B1 (en) 1983-01-13 1983-01-13 5-FLUORURACIL DERIVATIVES AND THEIR THERAPEUTIC USES AS CARCINOSTATIC AGENTS

Publications (2)

Publication Number Publication Date
FR2539412A1 FR2539412A1 (en) 1984-07-20
FR2539412B1 true FR2539412B1 (en) 1986-02-21

Family

ID=9284900

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8300457A Expired FR2539412B1 (en) 1983-01-13 1983-01-13 5-FLUORURACIL DERIVATIVES AND THEIR THERAPEUTIC USES AS CARCINOSTATIC AGENTS

Country Status (1)

Country Link
FR (1) FR2539412B1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240352B1 (en) * 1986-04-02 1992-12-16 Chisso Corporation 5-fluorouracil derivatives and processes for producing thereof
PL170961B1 (en) * 1991-08-14 1997-02-28 Procter & Gamble Pharma Method of obtaining novelurea derivatives useful as agents against arrythmia and fibrillation
EP1092432A1 (en) * 1999-10-15 2001-04-18 Societe De Conseils De Recherches Et D'applications Scientifiques S.A. (S.C.R.A.S.) Anti-ischemic compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5324951B2 (en) * 1973-11-28 1978-07-24
JPS607622B2 (en) * 1976-04-26 1985-02-26 三井東圧化学株式会社 1-Production method of carbamoyl-uracils
JPS5946509B2 (en) * 1976-11-04 1984-11-13 三井東圧化学株式会社 1-Substituted cyclohexylcarbamoyl-5-fluorouracils and their production method
JPS6011705B2 (en) * 1976-11-05 1985-03-27 小野薬品工業株式会社 5-Fluorouracil derivative compound
EP0010941B1 (en) * 1978-10-30 1982-05-12 Fujisawa Pharmaceutical Co., Ltd. 5-fluorouracil derivatives, preparation thereof and their pharmaceutical compositions
JPS5569569A (en) * 1978-11-21 1980-05-26 Mitsui Toatsu Chem Inc Carcinostatic
JPS55136267A (en) * 1979-04-08 1980-10-23 Tokyo Kinzoku Kogyo Kk Pyrimidine derivative

Also Published As

Publication number Publication date
FR2539412A1 (en) 1984-07-20

Similar Documents

Publication Publication Date Title
EP0706373A4 (en) TAXOL ENCAPSULATED IN LIPOSOMES AND METHOD OF USING SAME
BE889930A (en) INDOLE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USES
FR2547727B1 (en) PHARMACEUTICAL COMPOSITIONS
SE8206697L (en) HIGH-SOLUBILITY MEDICINAL PRODUCTS AND WAY TO PREPARE THESE
BE890024A (en) TRICYCLIC IMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES
IT1224795B (en) USE OF ACETYL D-CARNITINE IN THE THERAPEUTIC TREATMENT OF GLAUCOMA AND PHARMACEUTICAL COMPOSITIONS USEFUL IN SUCH TREATMENT
BE889929A (en) INDOLE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USES
IT1205337B (en) ETHEROARYL-AMINOMETHYLENE-DERIVED DERIVATIVES SUBSTITUTED FOR REGULATORY ACTIVITY OF THE HEART RHYTHM AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
NO843042L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CUMARIN DERIVATIVES
BE868882A (en) HALOGENOMETHYL DERIVATIVES OF ALPHA-AMINOACIDS, THEIR PREPARATION AND THEIR THERAPEUTIC USES
FR2562893B1 (en) DERIVATIVES OF HYDROXY-4-2H-1-BENZOTHIOPYRAN-2-ONE, THEIR PREPARATIONS AND APPLICATIONS IN THE RODENTICIDE FIELD
MC1440A1 (en) PYRROLIDINE DERIVATIVES, ITS PREPARATION AND THERAPEUTIC USES FOR THE TREATMENT OF CEREBRAL DEFICIENCY
BE843679A (en) 16,16-SPIROCYCLOALKYLPROSTAGLANDIN DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES
FR2539412B1 (en) 5-FLUORURACIL DERIVATIVES AND THEIR THERAPEUTIC USES AS CARCINOSTATIC AGENTS
DK131884A (en) PHARMACEUTICAL AGENTS WITH ANTINEOPLASTIC EFFECT
FR2505826B1 (en) ISOPRENYLAMINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS PREPARED THEREWITH
IT8449056A1 (en) DERIVATIVES OF 1- 2 DITOLATES THEIR PREPARATION AND THEIR USE AS MEDICATIONS
BE883943A (en) ENKAPHALINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES, IN PARTICULAR AS ANALGESICS
FR2608604B1 (en) 5-HYDROXYETHYL DERIVATIVES OF OXAZOLIDINONE-2, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC APPLICATIONS
IT1163107B (en) PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN GLAUCOMA TREATMENT
IT1157126B (en) N (VINBLASTIN-23-IL) AMINO ACID DERIVATIVES THEIR PREPARATION AND THERAPEUTIC APPLICATION
FR2558470B1 (en) STEROIDS OF THE TYPE (16, 17-A) CYCLOPENTANOPREGNENES AND THERAPEUTIC USES THEREOF, IN PARTICULAR AS ANTI-INFLAMMATORY AGENTS
IT1142304B (en) INDAN DERIVATIVES THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
BE868570A (en) TETRANAPHTALENESULPHONIC ACID DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USES
DK415087D0 (en) THERAPEUTIC AGENTS CONTAINING BENZHYDRYLTHIOMETHER DERIVATIVES

Legal Events

Date Code Title Description
ST Notification of lapse